Establishing Immune Tolerance in Multiple Sclerosis Using Peptide-Coupled Red Blood Cells

Time: 3:00 pm
day: Day Two


  • Development and clinical implementation of a GMP process for peptide coupling using red blood cells from individual patients
  • Review of the phase 1b trial including the clinical, safety and immunological data
  • Design and implementation of a phase 2 study for clinical proof-of-concept